The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating associations of diabetes, insulin use, and BMI with efficacy in patients with resected pancreatic cancer: An ancillary analysis of NRG Oncology/RTOG 9704.
 
Theodore S. Hong
Research Funding - Novartis (Inst); Taiho Pharmaceutical
 
Kathryn A. Winter
No Relationships to Disclose
 
Charles S. Fuchs
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Entrinsic Health; Five Prime Therapeutics; Genentech/Roche; Gilead Sciences; Lilly; Macrogenics; MedImmune; Merck; Pfizer; Sanofi; Takeda
 
William Regine
No Relationships to Disclose
 
Ross A. Abrams
No Relationships to Disclose
 
Howard Safran
No Relationships to Disclose
 
John Parker Hoffman
No Relationships to Disclose
 
Al Bowen Benson
Consulting or Advisory Role - Alchemia; Astellas Pharma; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech/Roche; Genomic Health; Infinity Pharmaceuticals; IntegraGen; Lilly/ImClone; Merck Serono; Merck/Schering Plough; National Cancer Institute; Pharmacyclics; Precision Therapeutics; Sanofi; Spectrum Pharmaceuticals; Taiho Pharmaceutical; Vicus Therapeutics
Research Funding - advanced accelerator applications; Alchemia; Amgen; Astellas Pharma; AVEO; Bayer/Onyx; EMD Serono (Inst); Genentech (I); Gilead Sciences; Infinity Pharmaceuticals; Merck Serono (Inst); Novartis
Travel, Accommodations, Expenses - Astellas Pharma; AVEO; Bayer; Boehringer Ingelheim; Dava Oncology; Genentech/Roche; Gilead Sciences; Lilly/ImClone; Sanofi; Spectrum Pharmaceuticals; TRM Oncology
 
John S. Macdonald
No Relationships to Disclose
 
Timothy Kasunic
No Relationships to Disclose
 
James Fredric Strauss
No Relationships to Disclose
 
Thomas A. DiPetrillo
Patents, Royalties, Other Intellectual Property - Patent for brachytherapy device
 
Philip J. Stella
Employment - CARET; Physician Resource Management
Leadership - Physician Resource Management
Stock and Other Ownership Interests - Physician Resource Management
 
Yuhchyau Chen
No Relationships to Disclose
 
John Peter Plastaras
Travel, Accommodations, Expenses - IBA
 
Christopher H Crane
No Relationships to Disclose